Christine Bekos - Gynecology

Author Information

Christine Bekos is affiliated with the Department of Obstetrics and Gynecology at the Medical University of Vienna, located in Spitalgasse 23, 1090 Vienna, Austria. Her research primarily focuses on various aspects of gynecologic oncology and related fields.

Research Contributions

Christine Bekos has made significant contributions to the field of gynecology, with a particular focus on ovarian cancer, vulvar cancer, and the prognostic parameters associated with these conditions. Her work includes studies on the role of nutritional status in ovarian cancer prognosis, the reliability of tumor testing for BRCA1 and BRCA2 mutations, and the prognostic value of immune-inflammation indices in vulvar cancer. She has also explored the expression of PD-1 and PD-L1 in ovarian and peritoneal metastases and their clinical outcomes, as well as the protective role of uterus preservation in vaginal prolapse surgery against postoperative urinary retention.

Aliases

Christine Bekos is also known by the aliases "C. Bekos" and "Christine Bekos."

Publication and Citation Metrics

Citation Count	372
h-index	14
Paper Count	29

Publications:

The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate

DOI: 10.1055/a-1608-1309

Year: 2022

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer

DOI: 10.3390/jpm11070593

Year: 2021

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome

DOI: 10.1038/s41598-021-85966-0

Year: 2021

Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis

DOI: 10.1080/2162402X.2020.1756130

Year: 2020

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer

DOI: 10.3802/jgo.2021.32.e1

Year: 2020

Uterus Preservation in Case of Vaginal Prolapse Surgery Acts as a Protector against Postoperative Urinary Retention

DOI: 10.3390/jcm9113773

Year: 2020

Prognostic Laboratory Parameters in Placental Abruption: A Retrospective Case-Control Study

DOI: 10.3390/jcm8040482

Year: 2019

Publisher Correction: Exercise-induced bronchoconstriction, temperature regulation and the role of heat shock proteins in non-asthmatic recreational marathon and half-marathon runners

DOI: 10.1038/s41598-019-48897-5

Year: 2019

Prognostic value of serum creatine level in patients with vulvar cancer

DOI: 10.1038/s41598-019-47560-3

Year: 2019

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach

DOI: 10.3390/cancers11050698

Year: 2019

What are the Survival Rates?

Where Are Intramuscular Injections Administered?

How do public health programs address menstruation and menopause issues?

Who is Eligible for a Uterus Transplant?

Why is breast cancer awareness important in gynecology?

Why Do Women Need More Calcium?

How Does Insurance Work?

How to Donate to a Public Cord Blood Bank?

What Can Karyotype Analysis Detect?

Who Can Benefit from Hormonal Injections?

Partnered Content Networks

Relevant Topics